Literature DB >> 26634381

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

N Colombo1, C Creutzberg2, F Amant3, T Bosse4, A González-Martín5, J Ledermann6, C Marth7, R Nout8, D Querleu9, M R Mirza10, C Sessa11.   

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
© The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adjuvant; consensus; endometrial neoplasms; practice guideline; surgery; treatment

Mesh:

Year:  2015        PMID: 26634381     DOI: 10.1093/annonc/mdv484

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  199 in total

1.  Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.

Authors:  Paolo Casadio; Francesca Guasina; Roberto Paradisi; Concetta Leggieri; Giacomo Caprara; Renato Seracchioli
Journal:  Oncologist       Date:  2018-01-09

2.  Vaginal brachytherapy for endometrial cancer.

Authors:  Peter Hass; Selvi Seinsch; Holm Eggemann; Tanja Ignatov; Stephan Seitz; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-05       Impact factor: 4.553

Review 3.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

4.  Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.

Authors:  Francesco Multinu; Jvan Casarin; Serena Cappuccio; Gary L Keeney; Gretchen E Glaser; William A Cliby; Amy L Weaver; Michaela E McGree; Stefano Angioni; Gavino Faa; Mario M Leitao; Nadeem R Abu-Rustum; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2019-05-22       Impact factor: 5.482

5.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

Review 6.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

7.  miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth.

Authors:  Lei Chang; Zhongfu Yuan; Huirong Shi; Yangyang Bian; Ruixia Guo
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

8.  The Advantage of Pinpoint Camera System With Indocyanine Green for Sentinel Lymph Node Micrometastasis Detection in Low Risk Endometrial Cancer.

Authors:  Alexandros Lazaridis; Stylianos Kogeorgos; Panagiotis Balinakos; Kitty Pavlakis; Theofani Gavresea; George Pistofidis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Low expression of developing brain homeobox 2 (Dbx2) may serve as a biomarker to predict poor prognosis in endometrial cancer.

Authors:  Xinlu Zhang; Yaping Wang; Shujun Zhao; Qiaohong Qin; Min Zhang; Yi Jiang; Hai Zhu; Hongyu Li
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.